Document:

Exhibit 10.13

 

 

Avricore
Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Wheelhouse at Center of Nascent Industry

 

October
13, 2021 08:30 ET | Source: Avricore Health Inc.

 

NEW
YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF)
today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands in the
InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.

 

To
view the full publication, “Real-World Data, Point-of-Care Testing Reshaping Healthcare, Detecting Diseases Sooner,” please
visit: https:/nnw.fm/MLmSr

 

Today
it seems almost unimaginable to wait days or weeks for results from a blood test, but that was the case only a few decades ago. Automated
equipment, portable devices and medical innovation have underscored a healthcare evolution that allows for faster diagnoses and subsequent
treatment to improve patient outcomes. Innovation remains at the heart of healthcare, keeping up with the times as doctors, patients
and insurance companies now expect near-instant results that detect disease at earlier and earlier stages, sometimes even before symptoms
present.

 

Early
detection and screening have been proven to save lives and billions of dollars, lending to the rise of point-of-care testing (POCT),
a nascent industry seeing exciting potential. POCT is the wheelhouse for Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF),
whose turnkey POCT-solution-branded HealthTab(TM) delivers real-time results, with the new technology currently being evaluated at leading
pharmacies in Canada with North American expansion planned for the future.

 

    	 

     

    

 

About
Avricore Health Inc.

 

Avricore
Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward.
Through its flagship offering HealthTab(TM), a wholly owned subsidiary, the company’s mission is to make actionable health information
more accessible to everyone by creating the world’s largest network of rapid-testing devices in community pharmacies.

 

For
more information about the company, visit www.AvricoreHealth.com.

 

NOTE
TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at http://nnw.fm/AVCRF

 

About
NetworkNewsWire

 

NetworkNewsWire
(NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks
that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an
extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire
to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of
more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW
brings its clients unparalleled visibility, recognition and brand awareness.

 

NNW
is where news, content and information converge.

 

To
receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

 

For
more information please visit https://www.NetworkNewsWire.com

 

Please
see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or
re-published: http://NNW.fm/Disclaimer

 

NetworkNewsWire
(NNW)

New York, New York

www.NetworkNewsWire.com

212.418.1217 Office

Editor@NetworkNewsWire.com

NetworkNewsWire
is part of the InvestorBrandNetworkExhibit
10.14

 

 

Avricore
Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) on Mission to Make Health Info Accessible to All

 

October
14, 2021 08:30 ET | Source: Avricore Health Inc.

 

NEW
YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) announces
the availability of a broadcast titled, “Real-World Data, Point-of-Care Testing Reshaping Healthcare, Detecting Diseases Sooner.”

 

To
hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast

 

To
view the full editorial, please visit: https:/nnw.fm/MLmSr

 

Insurers,
healthcare providers, life sciences companies and governments are challenged with rising costs and inconsistent outcomes. This wends
way to demand for real-world evidence to play a bigger role in study and monitoring because it is more accurate and is more cost efficient.
Furthermore, there is a paradigm shift ongoing in healthcare related to the patient mentality: younger generations are no longer passive
about their health journey, becoming increasingly proactive and expecting data-driven care.

 

And
then there are pharmacies, which are under pressure from all angles — regulators, competition and industry — and need to
generate additional revenue, which points squarely at adding services catering to the above market drivers. That’s where Avricore
Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) specializes, as a pharmacy service innovator focused on acquiring and developing
early-stage technologies aimed at moving pharmacy forward. The Vancouver-based company’s wholly owned HealthTab(TM) subsidiary
is commercializing an eponymous product that is unlike anything in pharmacies today. The solution is part of AVCR’s mission to
make actionable health information more accessible to all by creating the world’s largest network of rapid-testing devices in community
pharmacies.

 

    	 

    	 

    

 

About
Avricore Health Inc.

 

Avricore
Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward.
Through its flagship offering HealthTab(TM), a wholly owned subsidiary, the company’s mission is to make actionable health information
more accessible to everyone by creating the world’s largest network of rapid-testing devices in community pharmacies.

 

For
more information about the company, visit www.AvricoreHealth.com.

 

NOTE
TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at http://nnw.fm/AVCRF

 

About
NetworkNewsWire

 

NetworkNewsWire
(NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks
that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an
extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire
to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of
more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW
brings its clients unparalleled visibility, recognition and brand awareness.

 

NNW
is where news, content and information converge.

 

To
receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

 

For
more information please visit https://www.NetworkNewsWire.com

 

Please
see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or
re-published: http://NNW.fm/Disclaimer

 

NetworkNewsWire
(NNW)

New
York, New York

www.NetworkNewsWire.com

212.418.1217 Office

Editor@NetworkNewsWire.com

 

NetworkNewsWire
is part of the InvestorBrandNetworkExhibit
10.26

 

 

HEALTHTABTM
EXPANDS TO BRITISH COLUMBIA IN SELECT SHOPPERS DRUG MART® LOCATIONS

 

VANCOUVER,
BRITISH COLUMBIA – October 26, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”)
announces that it has expanded patient testing with the HealthTabTM platform in select Shoppers Drug Mart® pharmacies in British
Columbia, bringing its diabetes screening program to Western Canada for the first time.

 

“The
launch in Shoppers Drug Mart pharmacies in Ontario has been very successful and we are very happy to see the program lay the groundwork
for expansion,” said Hector Bremner, Avricore Health’s CEO. “Having a real-time patient observation program reporting
seamlessly across 3000kms is very unique and we are very proud to deliver this innovation.”

 

This
expansion builds off the Master Agreement signed with Shoppers Drug Mart Inc. to pilot the HealthTabTM platform in May of
this year which brings patients access to point-of-care blood screening and health-data management for potential risks for developing
diabetes and cardiovascular conditions through the HealthTabTM-integrated Afinion 2TM analyzers by Abbott Rapid Diagnostics.

 

“Patient
feedback, along with that of our pharmacists, has been very positive in Ontario with respect to HealthTabTM and we are evaluating
how more patients can benefit from this type of service,” said Frank Hack, Director of Complex Care at Shoppers Drug Mart. “In
coming to British Columbia, we are hoping to learn more about patient needs and serve them in the best way possible.”

 

Shoppers
Drug Mart® pharmacies in five cities have now received their HealthTabTM systems and will begin offering screening tests to
patients with known conditions associated with pre-diabetes, or already identified as diabetic, to provide diagnostic support and pharmacist-led
consultation services. They are located at:

 

	 	●	#5
    Road & Cambie: 11800 Cambie Rd, Richmond, BC
	 	●	Kensington
    Square: 6508 East Hastings St, Burnaby, BC
	 	●	Thurlow
    & Davie: 1125 Davie St, Vancouver, BC
	 	●	Cedar
    Hills: 12830 96th Avenue, Unit #6, Surrey, BC
	 	●	Hillside
    Shopping Centre: 1644 Hillside Ave, Victoria, BC

 

To
find a location near you, please visit: healthtab.com/locations

 

HealthTabTM
Market Fast Facts

 

	 	●	Point-of-Care
    Testing Market to reach $50.6 Billion USD in 2025 (Source)
	 	●	Glucose
    monitoring (diabetes related) to make up the largest growth with the sector. (Source)
	 	●	Nearly
    13.6 Million Canadians expected to diabetic or prediabetic by 2030, with many undiagnosed (Source)
	 	●	Over
    1 in 3 Americans, approximately 88 million people, have pre-diabetes (Source)
	 	●	Close
    to 160,000 Canadians 20 years and older are diagnosed with heart disease each year, often it’s only after a heart attack they
    are diagnosed. (Source)
	 	●	There
    are more that 10,000 pharmacies in Canada, 88,000 pharmacies in the US, nearly 12,000 in the UK.

 

    	 

    	 

    

 

 

About
HealthTabTM

 

HealthTabTM
is a turnkey point-of-care testing solution that combines best-in-class point-of-care technologies with a secure, cloud-based platform
for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results
on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases,
such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). HealthTabTM has also recently added capabilities for bacterial
and viral tests, such as strep and COVID-19.

The HealthTabTM network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role
in primary care delivery, while empowering patients to take more control of their health. It also reduces costs and waiting times and
provides many potential revenue streams including equipment leasing & consumables, direct access testing, disease prevention &
management programs, sponsored health programs, decentralized clinical trials, real world data (RWD) sets, and third-party app integration
through API.

About
Avricore Health Inc.

 

Avricore
Health Inc. (TSXV: AVCR) is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving
pharmacy forward. Through its flagship offering HealthTabTM (a wholly owned subsidiary), its mission is to make actionable health
information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies.

 

Contact:

 

Avricore
Health Inc.

Hector
Bremner, CEO 604-773-8943 

info@avricorehealth.com 

www.avricorehealth.com

 

Cautionary
Note Regarding Forward-Looking Statements 

 

Information
in this press release that involves Avricore Health’s expectations, plans, intentions or strategies regarding the future are forward-looking
statements that are not facts and involve a number of risks and uncertainties. Avricore Health generally uses words such as “outlook,”
“will,” “could,” “would,” “might,” “remains,” “to be,” “plans,”
“believes,” “may,” “expects,” “intends,” “anticipates,” “estimate,”
“future,” “positioned,” “potential,” “project,” “remain,” “scheduled,”
“set to,” “subject to,” “upcoming,” and similar expressions to help identify forward-looking statements.
In this press release, forward-looking statements include statements regarding: the completion of the placement and the expected timing
thereof and the Company’s expected use of proceeds from the placement; the unique features that the HealthTabTM
platform offers to pharmacists and patients. Forward-looking statements reflect the then-current expectations, beliefs, assumptions,
estimates and forecasts of Avricore Health’s management. The forward-looking statements in this press release are based upon information
available to Avricore Health as of the date of this press release. Forward-looking statements believed to be true when made may ultimately
prove to be incorrect. These statements are not guarantees of the future performance of Avricore Health and are subject to a number of
risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current
expectations, including without limitation: failure to meet regulatory requirements; changes in the market; potential downturns in economic
conditions; and other risk factors described in Avricore’s public filings. These forward-looking statements speak only as of the
date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence
of future events or circumstances, unless otherwise required to do so by law.

 

Neither
the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]